Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1970d ago.

Commenters (1)

• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%